KEGG DRUG: Hepatitis B immune globulin

DRUG: Hepatitis B immune globulin

Entry

D04431                      Drug

Name

Hepatitis B immune globulin (USP);
Hepatitis B immnoglobulin;
Bayhep B (TN);
Fovepta (TN)

Product

HEPAGAM B (Saol Therapeutics), NABI-HB (ADMA Biologics)

Remark

ATC code:

J06BB04

Product:

D04431<US>

Efficacy

Immunizing agent (passive), Prophylactic (hepatitis B)

Disease

Hepatitis B [DS:H00412]

Brite

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BB Specific immunoglobulins
     J06BB04 Hepatitis B immunoglobulin
      D04431  Hepatitis B immune globulin (USP) <US>
USP drug classification [BR:br08302]
Immunological Agents
  Immunoglobulins
   Hepatitis B Immune Globulin
    D04431  Hepatitis B immune globulin (USP)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
  D04431

Other DBs

PubChem:

47206301

LinkDB

» Japanese version » Back

DBGET integrated database retrieval system